ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 119 out of 2035

$695K Total Retail Price of All Prescriptions

Rank: 140 out of 2035

444 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 9,854 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 477 390 1 1
CITALOPRAM HBR 424 375 2 20
LEVOTHYROXINE SODIUM 331 302 3 4
LISINOPRIL 317 265 4 3
FUROSEMIDE 297 266 5 7
HYDROCODONE-ACETAMINOPHEN 251 203 S3 6 2
POTASSIUM CHLORIDE 247 220 7 18
METOPROLOL TARTRATE 243 221 8 8
METFORMIN HCL 230 204 9 9
BUMETANIDE 193 186 10 79
AMLODIPINE BESYLATE 171 167 11 6
WARFARIN SODIUM 168 138 12 11
RANITIDINE HCL 163 148 13 28
DIVALPROEX SODIUM 159 151 14 75
NAMENDA 156 145 15 37
TRAMADOL HCL 152 125 16 19
OMEPRAZOLE 149 123 17 5
ATENOLOL 143 118 18 10
GABAPENTIN 142 114 19 14
ESCITALOPRAM OXALATE 142 108 19 77
DONEPEZIL HCL 138 118 21 24
SERTRALINE HCL 137 113 22 23
SYNTHROID 134 126 23 83
CARVEDILOL 133 122 24 22
TRAZODONE HCL 128 122 25 50
LOVASTATIN 115 102 26 33
CYMBALTA 111 85 27 59
DIGOXIN 105 105 28 67
LANTUS 105 80 28 40
MELOXICAM 104 88 30 56
TAMSULOSIN HCL 102 102 31 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 98 32 26
METOPROLOL SUCCINATE 98 75 33 16
OLANZAPINE 93 86 34 121
HYDROCHLOROTHIAZIDE 91 86 35 12
QUETIAPINE FUMARATE 87 79 36 70
CLOPIDOGREL 87 79 36 30
ALLOPURINOL 82 54 38 34
FINASTERIDE 76 76 39 105
ISOSORBIDE MONONITRATE ER 73 60 40 32
GLIPIZIDE 72 51 41 54
DIOVAN 67 67 42 76
PANTOPRAZOLE SODIUM 66 57 43 42
PRAVASTATIN SODIUM 66 57 43 17
LOSARTAN POTASSIUM 65 45 45 15
DOXAZOSIN MESYLATE 62 62 46 111
JANUVIA 61 61 47 85
FLUOXETINE HCL 61 58 47 81
RAMIPRIL 58 57 49 135
CYCLOBENZAPRINE HCL 58 42 R 49 64
CLONIDINE HCL 56 51 51 61
PHENYTOIN SODIUM EXTENDED 54 30 52 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.